Trial
NCT02441309
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Oxford
Collaborators
Millennium: The Takeda Oncology Company; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS Trust; European Commission
Condition
Osteosarcoma
Intervention
Mifamurtide
Why stopped
Failed to recruit sufficient numbers of patients in the funded period
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-13